10-103089678-T-TTCCTCC
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP3
The NM_001351169.2(NT5C2):c.1674_1679dupGGAGGA(p.Glu559_Glu560dup) variant causes a disruptive inframe insertion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000962 in 1,559,910 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001351169.2 disruptive_inframe_insertion
Scores
Clinical Significance
Conservation
Publications
- hypomagnesemia, seizures, and intellectual disability 1Inheritance: AR, SD, AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Illumina, Labcorp Genetics (formerly Invitae)
- renal hypomagnesemia 6Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- familial primary hypomagnesemia with normocalciuria and normocalcemiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NT5C2 | NM_001351169.2 | c.1674_1679dupGGAGGA | p.Glu559_Glu560dup | disruptive_inframe_insertion | Exon 19 of 19 | ENST00000404739.8 | NP_001338098.1 | |
CNNM2 | NM_017649.5 | c.*12510_*12515dupCTCCTC | 3_prime_UTR_variant | Exon 8 of 8 | ENST00000369878.9 | NP_060119.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NT5C2 | ENST00000404739.8 | c.1674_1679dupGGAGGA | p.Glu559_Glu560dup | disruptive_inframe_insertion | Exon 19 of 19 | 1 | NM_001351169.2 | ENSP00000383960.3 | ||
CNNM2 | ENST00000369878.9 | c.*12510_*12515dupCTCCTC | 3_prime_UTR_variant | Exon 8 of 8 | 1 | NM_017649.5 | ENSP00000358894.3 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152034Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000907 AC: 2AN: 220626 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000497 AC: 7AN: 1407876Hom.: 0 Cov.: 30 AF XY: 0.00000429 AC XY: 3AN XY: 699662 show subpopulations
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152034Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74260 show subpopulations
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 45 Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with NT5C2-related conditions. This variant is present in population databases (rs751199209, gnomAD 0.004%). This sequence change disrupts the translational stop signal of the NT5C2 mRNA. It is expected to extend the length of the NT5C2 protein by 2 additional amino acid residues. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at